Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026379

Options or other derivatives

  • Chief Strategy Officer acquired 506,276 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Randall Charles Hiram Chief Strategy Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +116,321 116,321 D: show line 1 in the form
Randall Charles Hiram Chief Strategy Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +116,321 116,321 D: show line 2 in the form
Randall Charles Hiram Chief Strategy Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +116,321 116,321 D: show line 3 in the form
Randall Charles Hiram Chief Strategy Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +11,632 11,632 D: show line 4 in the form
Randall Charles Hiram Chief Strategy Officer 2021-10-22 Grant or award · Earnout Rights (Restricted Stock Units) +145,681 145,681 D: show line 5 in the form
Loading xslF345X03/ownership.xml…